Autonomic Nervous System Dysfunction Completed Phase 4 Trials for DB08868 (Fingolimod)

IndicationStatusPhase
DBCOND0068757 (Autonomic Nervous System Dysfunction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02048072Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MSBasic Science